Urinary tract infections: a retrospective cohort study of (mis)matching antimicrobial therapy and clinical outcome among Finnish adults
2024

Urinary Tract Infections and Antimicrobial Therapy Outcomes

Sample size: 317 publication 10 minutes Evidence: moderate

Author Information

Author(s): Anu Patjas, Sakari Jokiranta, Anu Kantele

Primary Institution: University of Helsinki

Hypothesis

How does mismatching antimicrobial treatment affect clinical outcomes in urinary tract infections caused by ESBL-producing and non-ESBL-producing Enterobacterales?

Conclusion

Microbiological matching of antimicrobial therapy is associated with better clinical outcomes in urinary tract infections compared to mismatching.

Supporting Evidence

  • 91.6% of non-ESBL-PE cases had matching antimicrobial therapy compared to 46.9% of ESBL-PE cases.
  • Clinical cure rates were 82.6% for non-ESBL-PE and 62.2% for ESBL-PE infections.
  • Mismatching therapy did not significantly affect relapse/reinfection rates.

Takeaway

This study looked at how well antibiotics work for urinary infections caused by different bacteria, finding that using the right antibiotic helps people get better.

Methodology

The study involved a retrospective cohort analysis of patients aged 18-65 with community-acquired urinary tract infections, comparing clinical outcomes based on microbiological matching of antibiotics.

Potential Biases

Potential recall bias may have affected the accuracy of patient-reported outcomes.

Limitations

The study may have overrepresented complicated or recurrent UTIs due to its reliance on positive urine cultures for recruitment.

Participant Demographics

The median age was 51 years, with 89.3% females and 21.8% of infections classified as upper UTIs.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1093/jacamr/dlae188

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication